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Abstract
To determine if obesity, blood pressure, markers of inflammation, and insulin resistance are
associated with cardiac structure in African American adolescents, a cross-sectional study was
conducted on a cohort oversampled for high blood pressure and obesity. Measurements included:
anthropometrics, blood pressure, homeostasis model assessment to assess insulin resistance, high
sensitivity C-Reactive Protein, and plasma adipokines (adiponectin, Interleukin-6, Plasminogen
Activator Inhibitor-1. Echocardiogram measurements were left ventricular mass index (g/m2.7),
left ventricular relative wall thickness, left atrial diameter index (mm/m) and left ventricular
diastolic time intervals. Left atrial diameter index (r2 = 0.25) was associated with body mass index
systolic blood pressure, and female gender. Left ventricular mass index (r2 = 0.35) variation was
associated with body mass index systolic blood pressure, heart rate, age, and male gender. Left
ventricular relative wall thickness (r2 = 0.05) was associated with homeostasis model assessment.
Tissue diastolic intervals were not associated with any risk factor. Inflammatory markers and
adipokines were associated with body mass index but were not independently associated with any
echo measures. In African American adolescents, body mass index and systolic blood pressure but
not inflammatory markers or adipokines are important correlates of left atrial size and left
ventricular mass.
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Introduction
There are racial differences in development of cardiovascular disease, with African
Americans adversely affected. Compared to Caucasians, African Americans and males have
been shown to have increased left ventricular mass (LVM).1-3 There is inconsistent data on
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the association of insulin resistance to LV and left atrial (LA) size.4-6 Bibbins-Domingo et
al7 followed healthy, young adults over 20 years and found significantly more cases of heart
failure in African American young adults than Caucasians. Obesity and obesity-related risk
factors including high blood pressure (BP) lead to cardiovascular morbidity through
inflammation and endothelial damage.8 In African-American adults, DeLoach et al. have
shown an association between body mass index (BMI) and elevated pro-inflammatory
adipokine levels (tumor necrosis factor alpha (TNF-α), interleukin-6 (IL6), plasminogen
activator (PAI-1) and high sensitivity c-reactive protein (CRP)), which was unrelated to
BP.9
We recruited an African-American adolescent cohort oversampled for the presence of
obesity and pre- and stage 1 hypertension to further assess early cardiovascular and
metabolic co-morbidities of evolving cardiovascular risk. , We have previously shown in
this cohort that both adverse cardiac structure and markers of inflammation and insulin
resistance are strongly associated with intermediate as well as high risk BP and obesity
phenotypes.10 The purpose of this study was to examine in greater depth these factors and
how they are associated with cardiac structure. Associations of cardiac structure with BP,
BMI, a pro-inflammatory adipokine profile (low adiponectin, elevated IL6, PAI-1 and CRP),
insulin resistance, and urinary sodium were investigated.
Methods
Participants
Healthy adolescents, ages 13-18 years and 47% female, were recruited through community
advertisements and referral from primary care offices between 2009 and 2011 as part of a
study investigating co-morbidities of obesity and elevated BP in African Americans;
participants were oversampled for obesity (BMI ≥95th percentile, Centers for Disease
Control United States graphs) and high risk BP defined as average BP ≥120/80 mm Hg. 11
Participants were Tanner 4 or higher. Exclusions included secondary hypertension, diabetes,
renal disease, cardiovascular disease, autoimmune disease, thyroid disease, sickle cell
disease, eating disorders, and use of steroids. Children with stage 2 hypertension or with a
history of taking antihypertensive medication were not enrolled. Children taking behavioral
medications on a stable regimen (the same dose at each study visit; n=5) were included. The
most common medications taken by participants were for asthma, allergies, or birth control.
The study protocol was approved by the Institutional Review Boards of Thomas Jefferson
University and A. I. DuPont Hospital for Children. Written informed consent was obtained
from 18-year-old participants, while consent was obtained from the parent or guardian at
enrollment and assent was obtained from the child if age <18 years.
Study Procedures
Information regarding health status, medication use, and health related behaviors were
obtained by self-report of each participant or guardian. Birth weight was also obtained by
self-report. BMI was calculated as weight (kg) divided by height squared (m2). Obesity was
defined as BMI ≥ 95th percentile for age and gender. BP measurements were obtained by
auscultation, seated, following a 10-minute rest and performed on the right arm using a cuff
large enough to encircle 80% of the subject’s upper arm. The average of three successive
measurements of systolic BP and diastolic BP on two separate visits was used as the BP
value. For adolescents with high BP, a third set of BP measurements were obtained to ensure
that the average of all BP measurements were ≥120 systolic or ≥80 diastolic mm Hg. BP
percentiles were also calculated based on population-standardized BP Z-scores.11 In a sub-
group of adolescents, 24 hour ambulatory blood pressure monitoring (ABPM) was
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conducted using the SpaceLabs™ 90207 device, an oscillometric BP monitor that has been
validated in the pediatric population. All participants were Tanner stage 4 or fully mature.
Each participant underwent 2-dimensional guided echocardiography to evaluate LA
diameter, LV geometry and mass. Measurements of the LA diameter, LV internal
dimension, interventricular septal thickness, and posterior wall thickness during diastole
were made according to methods established by the American Society of
Echocardiography.12 LA diameter was indexed by height (m). Left ventricular mass (LVM)
was calculated from the equation LVM (g) = 0.81 [1.04 (interventricular septal thickness +
posterior wall thickness + LV end diastolic internal dimension)3 − (LV end diastolic internal
dimension)3 +0.06. LVM index (LVMI) was calculated as LVM/m2.7.11 LV hypertrophy in
children and adolescents is defined as LVMI ≥95th percentile on sex specific normative
LVMI data.13 LV relative wall thickness was calculated as the ratio of twice the LV
posterior wall thickness in diastole to LV internal diameter in diastole. LV geometry was
assessed as normal, concentric remodeling, eccentric LV hypertrophy, or LV hypertrophy
with concentric remodeling based on the presence of LVMI above or below the 95th
percentile and LVRWT above or below 0.41.14 Tissue Doppler analysis of the lateral mitral
valve annulus was performed and values from sequential beats were averaged. Diastolic
function was calculated as: LV diastolic time intervals (LVDTI) = E/Ea. Heart rate (HR)
was calculated from the M Mode tracing. A single echocardiographer and observer (SG)
performed and interpreted the data related to echocardiographic assessment. Coefficient of
variation for intra-reader repeat studies (n=30) was < 8% for all variables.
Participants returned to the clinical research unit following an overnight fast. Each
participant saved the first morning voided urine sample (with the time interval from the
previous void) and brought the sample to the visit. An indwelling venous catheter was
placed and a fasting blood sample was obtained for laboratory studies. Plasma glucose
concentration was analyzed with the glucose oxidase technique (YS Model 27; Glucostat,
Yellow Springs, OH). Plasma insulin concentration was determined with a solid phase
radioimmunoassay (Coat-a-Count; Diagnostic Products Corp, Los Angeles, CA). Insulin
resistance was estimated using the homeostasis model assessment of insulin resistance
(HOMA).15 Plasma was saved from the fasting blood samples and stored at −80 degrees
centigrade for later assay of adiponectin and the inflammatory cytokines high sensitivity C
Reactive Protein (CRP), IL6, PAI-1 (TNF-α and Tumor Necrosis Factor-alpha receptor
(TNF-αR). All assays for the cytokines were performed by ELISA in duplicate using
commercially available kits. Kits for Adiponectin (total), IL-6, TNF-α, TNF-αR and CRP
were obtained from (R&D Systems, Minneapolis, MN). The kits for PAI-1 were obtained
from (Aniara, Mason, OH). The coefficient of variation for these assays was consistently
<10% and most <6%.
Statistical analyses
Categorical variables were summarized by frequency counts and percentages. Continuously
measured study variables were summarized by measures of central tendency and variability
(arithmetic mean and standard deviation if approximately normally distributed or geometric
mean and first and third quartiles [Q1, Q3] if substantially skewed). Substantially skewed
data were natural-log transformed for all analyses. Univariate comparisons were made for
study variables across groups defined by LADI tertiles and the 4 LVMI/LV relative wall
thickness study groups as defined above. ANOVA F-tests were used to evaluate differences
in means and Fisher’s exact tests were used to evaluate differences in proportions.
Adjustments were made to these p-values to help control the overall false discovery rate.16
The significance level for all tests was set in advance at α = 0.05.
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Multiple regression methods were used to fit models to each of the dependent variables
LADI, LVMI, LV relative wall thickness, and LVDTI. For each, we applied a multi-stage
model selection procedure. In the first stage, we regressed the dependent variable on age,
gender, BMI z-score, SBP z-score, and heart rate in beats per minute (bpm). The residuals
from this model were then regressed in the second stage of selection where we used the
hybrid Least Angle Regression method with the Mallow’s Cp criterion suggested by Efron
et al. (2004)17 to select variables that substantially contributed to predicting the dependent
variable independently of the contributions from the first stage model variables. The
variables considered in the second stage included HOMA, IL-6, PAI-1, adiponectin, TNF-α,
TNF-αR, and CRP. The third stage entailed including the selected variables from second
stage into one model with variables from stage 1. Each of the continuous variables were
mean centered prior to modeling. Results on regression coefficients and 95% confidence
intervals from the full models, including all variables considered, and the selected models
are presented.
All statistical analyses were conducted using SAS version 9.2 (SAS Institute, Inc., Cary,
NC, USA).
Results
Total enrollment for the study was 301 adolescents; complete data were available for this
analysis on 280 participants. Those with incomplete data were phenotypically similar to the
analyzed cohort. Forty eight percent of the participants were female; the mean age was 16
years (range 13-18 years); the lean normotensive group comprised 37% of the cohort, the
lean high risk BP group 12%, the obese normal BP group 34%, and the obese high risk BP
group 17%. Participant ages ranged from 13-18 years with a mean of 16 years. Gender
distribution was similar with regard to obesity but there were significantly fewer females
with high BP (38%, p=0.02). Age was significantly associated with BP (p=0.01). Data on
echocardiographic measures are shown in Table 1. These values are generally comparable to
distributions presented in the literature.
Participants were stratified into three groups (low, moderate, high) by tertiles of LADI.
Study variables within each LADI group are shown in Table 2. In univariate analysis, there
is a statistically significant association of LADI with BMI (p<0.01BMI z-score (p<0.01),
waist circumference (p<0.01), fasting insulin (p<0.01), HOMA (p<0.01), PAI-1 (p<0.01),
CRP (p<0.01), and LVMI (p<0.01).
Participants were also stratified according to LV geometry classification. Study variables for
each LV geometry group are provided in Table 3. BMI and SBP are significantly associated
with LVMI and geometry classification. Relationships of PAI1 and HOMA with increased
LVMI were seen but the strength of these was weaker than for LADI. Other relationships of
marginal significance were seen but these showed inconsistent patterns. In those with
concentric geometry, LVDTI was higher suggesting these individuals may have early
diastolic dysfunction.
Further analysis was performed by dividing participants based on BP and BMI designation.
Obesity was significantly associated with elevated fasting insulin (p<0.01), HOMA
(p<0.01), IL6 (p=0.01), PAI-1 (p<0.01), TNF-αR (p<0.01), CRP (p<0.01) and lower
adiponectin (p<0.01). On the other hand, high BP was only significantly associated with
elevated HOMA (p=0.01) and PAI-1 (p=0.02).
Among the obese adolescents with normal BP, 24% met echocardiographic criteria for LV
hypertrophy based on LVMI >95th percentile.13 To exclude the possibility of masked
hypertension accounting for LV hypertrophy in this group, a sample of the obese normal BP
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adolescents with and without LV hypertrophy were recalled for 24 hour ambulatory BP
monitoring. Ambulatory BP monitoring studies were completed on 51 obese normotensive
adolescents, including 23 with LV hypertrpophy and 28 without LV hypertrophy. There
were no differences in BMI or average BP between those with and without LV hypertrophy.
There were also no differences in any of the ambulatory BP monitoring parameters and no
cases of masked hypertension were detected.
Table 4 shows results of linear regression models to identify correlates of LADI, LVMI, and
LV relative wall thickness. After model selection, variation in LADI was significantly
associated with BMI (β=0.13, p<0.01), female gender (β=0.08, p=0.02), and SBP z-score
(β=0.05, p=0.02); and LVMI variation was significantly associated with BMI z-score (β =
3.63, p<0.01), age (β = 0.70, p<0.01), female gender (β = −3.65, p<0.01), SBP (β = 1.09,
p=0.02), and inversely with HR (β = −0.13, p<0.01). Although significant in univariate
models, inflammatory markers were not significantly associated with LADI or LVMI after
adjustment for other variables, particularly BMI. LV relative wall thickness was weakly
associated with HOMA (β = 0.02, p=0.01). For LV DTI only a weak correlation with TNF-
αR was present.
Discussion
The major finding of this study is that BMI is the factor most strongly associated with LADI
and LV structure in a cohort of African American adolescents. BMI is associated with a pro-
inflammatory adipokine profile and HOMA. In univariate analyses, inflammatory factors
and HOMA are associated with LADI and LV structure. However, after adjustment for
BMI, these associations disappear. BP is also associated with heart size and geometry but to
a lesser extent than BMI. HOMA has a weak relationship to LV relative wall thickness. The
magnitude of these relationships to BMI and BP are similar to other epidemiologic studies in
this age group.3, 18 LV DTI was generally unrelated to cardiovascular risk factors, although
a weak relationship to those with concentric geometry was seen. Ambulatory BP monitoring
in a subset of the cohort with increased LV mass excluded masked hypertension as a cause.
To our knowledge, this is the first study to evaluate the association of cardiovascular risk
factors, inflammatory markers, adipokines, and insulin resistance with echocardiographic
measurements in African American adolescents.
Enlargement of the LA in adults predicts increased cardiovascular morbidity (heart failure,
stroke, atrial fibrillation) and mortality.19, 20 LA volume index has been shown to provide
similar predictability for heart failure, hospitalization, and mortality as LV ejection fraction
in adults with coronary artery disease.20 In children, BMI z-score has been reported to be
independently associated with LA size.21, 22; and in hypertensive adults, LA size increases
as a function of body size..23 In Native American adolescents, similar relationships to LA
size have been found.24 These associations are important as data from the Bogalusa Heart
Study have shown that, compared to Caucasians, African Americans are more likely to
become hypertensive, with onset of hypertension occurring at a younger age.25 Further study
is needed on LADI as a marker of cardiac target organ injury at a young age.
LV hypertrophy is a manifestation of target organ injury detectable in children with
hypertension.11 LV hypertrophy is associated with BMI and BP and associations similar to
those found in this study have been previously published.3,24 A recent study has shown that
higher birth weight is also associated with increased LVM.26 In this study, no significant
associations of birth weight with LVM were detected (data not shown). However our data on
birth weight were obtained by self-report of the parent, guardian, or participant and were not
verified in birth records. Moreover, the birth weight could not be recalled in 30% of the
participants. Therefore, associations of birth weight with cardiac mass could not be
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determined in our African American adolescent cohort. Among African American adults
with LV hypertrophy, there is a significant increase in cardiovascular mortality, independent
of BMI and BP.27 The adolescent participants with high BP in this study did not have
clinically confirmed hypertension and most had average BP levels in the range of
prehypertension. The results of this study demonstrate that BMI and BP related target organ
injury to the heart occurs early in life in association with modest elevations in BP.
Correlates of LV relative wall thickness have not been studied in younger generally healthy
individuals. Most studies that examine these cardiac parameters have been in children with
chronic hypertension or severe obesity; these children have significantly increased LV
relative wall thickness and abnormal cardiac geometry, particularly those with
hypertension.28-30 Elevated BP at night on ambulatory monitoring may contribute to
concentric remodeling. A recent population-based Italian study showed a relationship of
elevated triglyceride to HDL ratio (a marker of insulin resistance), with LV relative wall
thickness.31 Body adiposity may also be correlated with LV relative wall thickness.32 In our
cohort, where adolescents with severe obesity and chronic hypertension were excluded, we
found a weak relationship of LV relative wall thickness with insulin resistance estimated by
HOMA. Collectively, these studies suggest chronic exposure to severe obesity and/or
hypertension may have a significant impact on LV relative wall thickness. Among
adolescents with less severe BP elevation or obesity, insulin resistance may also have a
subtle impact.
Pulsed-wave Tissue Doppler Imaging is used to assess ventricular function by measuring
regional systolic and diastolic myocardial velocities.33 LVDTI assessment of diastolic
function is load independent compared to conventional pulsed wave Doppler measurement.
In this study no significant associations with BP, BMI, or other risk markers were identified.
LVTDI was increased in those with concentric geometry suggesting that diastolic function
may be affected in those with excess LV wall thickness for a given degree of LV mass.
These findings are consistent with those of Border et al.33 We did not find associations with
BP or BMI as in other studies in cohorts with more severe hypertension or obesity.28, 34
Using different measures of diastolic function than in this study, the Strong Heart Study
uncovered associations of adverse diastolic function with obesity and metabolic syndrome in
Native American adolescents.24
Limitations
Because the study is based on a cross-sectional design, only associations can be examined.
Children at the extremes of the blood pressure and BMI distributions were excluded.
Prospective studies that examine adolescents longitudinally are needed to determine the
factors that predict increasing LADI and unfavorable LV geometry; inflammatory markers,
adipokines, and insulin resistance might emerge as determinants if subsequent progression
in LADI and LV geometry. More sophisticated echocardiographic function such as speckle
tracking techniques might add additional cardiac function information. The sample size of
this study is relatively small and limited to one ethnic group, thus statistical power and
generalizability may be limited. Because the cohort was oversampled for obesity and
elevated blood pressure we compared the distribution of BMI and BP to the most recent
National Health And Nutrition Examination Survey, and found that average BMI and BP
were higher than those distributions. Thus, prevalence of adverse LV geometry and
distribution of LA size are skewed compared to the general African-American adolescent
population.
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Conclusions
Obesity and obesity development are strongly associated with future hypertension, thus, the
inflammatory milieu associated with obesity described in this study could contribute to
injury to the microcirculation, a more rapid rise in BP with aging, and further cardiac end
organ injury.35, 36 Obesity is associated with an increase in cardiac index and a
hyperdynamic circulation.37 Whether these consequences are sufficient by themselves or are
mediated by other obesity-associated metabolic changes is difficult to assess from current
clinical studies. Regardless, the evolution of adverse cardiac structure begins in youth.
Further longitudinal studies will be important to better understand the complex mechanism
of adverse changes in LV geometry and LA size in African-Americans and other ethnic
groups.
Acknowledgments
All authors were involved in all phases of writing this paper from data collection to analysis and drafting the ms,
and all had final approval of the submitted and published versions.
Funding Source: NIH/NHLBI grant HL092030
Abbreviations
LVM(I) left ventricular mass (index)
LA(DI) left atrium (diameter index)
BP blood pressure
BMI body mass index
TNF-α (R) tumor necrosis factor alpha (receptor)
IL-6 interleukin-6
PAI-1 plasminogen activator
CRP high sensitivity C-reactive protein
LVDTI LV diastolic time intervals
HR heart rate
HOMA homeostasis model assessment
References
1. Dekkers C, Treiber FA, Kapuku G, Van Den Oord EJ, Snieder H. Growth of left ventricular mass in
african american and european american youth. Hypertension. 2002; 39:943–951. [PubMed:
12019274]
2. Gardin JM, Wagenknecht LE, Anton-Culver H, Flack J, Gidding S, Kurosaki T, Wong ND, Manolio
TA. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy
young black and white adult men and women. The cardia study. Coronary artery risk development
in young adults. Circulation. 1995; 92:380–387. [PubMed: 7634452]
3. Urbina EM, Gidding SS, Bao W, Pickoff AS, Berdusis K, Berenson GS. Effect of body size,
ponderosity, and blood pressure on left ventricular growth in children and young adults in the
bogalusa heart study. Circulation. 1995; 91:2400–2406. [PubMed: 7729027]
4. Urbina EM, Gidding SS, Bao W, Elkasabany A, Berenson GS. Association of fasting blood sugar
level, insulin level, and obesity with left ventricular mass in healthy children and adolescents: The
bogalusa heart study. Am Heart J. 1999; 138:122–127. [PubMed: 10385774]
Gidding et al. Page 7
Pediatr Cardiol. Author manuscript; available in PMC 2015 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
5. Litwin M, Sladowska J, Syczewska M, Niemirska A, Daszkowska J, Antoniewicz J, Wierzbicka A,
Wawer ZT. Different bmi cardiovascular risk thresholds as markers of organ damage and metabolic
syndrome in primary hypertension. Pediatr Nephrol. 2008; 23:787–796. [PubMed: 18253758]
6. Hirschler V, Acebo HL, Fernandez GB, de Lujan Calcagno M, Gonzalez C, Jadzinsky M. Influence
of obesity and insulin resistance on left atrial size in children. Pediatric diabetes. 2006; 7:39–44.
[PubMed: 16489973]
7. Bibbins-Domingo K, Pletcher MJ, Lin F, Vittinghoff E, Gardin JM, Arynchyn A, Lewis CE,
Williams OD, Hulley SB. Racial differences in incident heart failure among young adults. N Engl J
Med. 2009; 360:1179–1190. [PubMed: 19297571]
8. Balagopal PB, de Ferranti SD, Cook S, Daniels SR, Gidding SS, Hayman LL, McCrindle BW,
Mietus-Snyder ML, Steinberger J. Nontraditional risk factors and biomarkers for cardiovascular
disease: Mechanistic, research, and clinical considerations for youth: A scientific statement from the
american heart association. Circulation. 2011; 123:2749–2769. [PubMed: 21555711]
9. DeLoach S, Huan Y, Keith SW, Martinez Cantarin MP, Falkner B. Relationship of blood pressure
and obesity with inflammatory cytokines among african americans. Therapeutic advances in
cardiovascular disease. 2011; 5:149–157. [PubMed: 21558084]
10. Falkner B, Deloach S, Keith SW, Gidding SS. High risk blood pressure and obesity increase the
risk for left ventricular hypertrophy in african-american adolescents. J Pediatr. 2013; 162:94–100.
[PubMed: 22817908]
11. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and
adolescents. Pediatrics. 2004; 114:555–576. [PubMed: 15286277]
12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman
MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ.
Recommendations for chamber quantification: A report from the american society of
echocardiography’s guidelines and standards committee and the chamber quantification writing
group, developed in conjunction with the european association of echocardiography, a branch of
the european society of cardiology. J Am Soc Echocardiogr. 2005; 18:1440–1463. [PubMed:
16376782]
13. Khoury PR, Mitsnefes M, Daniels SR, Kimball TR. Age-specific reference intervals for indexed
left ventricular mass in children. J Am Soc Echocardiogr. 2009; 22:709–714. [PubMed: 19423289]
14. de Simone G, Daniels SR, Kimball TR, Roman MJ, Romano C, Chinali M, Galderisi M, Devereux
RB. Evaluation of concentric left ventricular geometry in humans: Evidence for age-related
systematic underestimation. Hypertension. 2005; 45:64–68. [PubMed: 15557389]
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model
assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin
concentrations in man. Diabetologia. 1985; 28:412–419. [PubMed: 3899825]
16. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach
to multiple testing. Journal of the Royal Statistical Society. 1995; B:289–300.
17. Efron B, Hastie T, Johnstone I, Tibshirani R. Least angle regression (with discussion). Annals of
Statistics. 2004; 32:407–499.
18. Schieken RM, Schwartz PF, Goble MM. Tracking of left ventricular mass in children: Race and
sex comparisons: The mcv twin study. Medical college of virginia. Circulation. 1998; 97:1901–
1906. [PubMed: 9609082]
19. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic
atrial fibrillation. The framingham heart study. Circulation. 1994; 89:724–730. [PubMed:
8313561]
20. Ristow B, Ali S, Whooley MA, Schiller NB. Usefulness of left atrial volume index to predict heart
failure hospitalization and mortality in ambulatory patients with coronary heart disease and
comparison to left ventricular ejection fraction (from the heart and soul study). Am J Cardiol.
2008; 102:70–76. [PubMed: 18572038]
21. Ayer JG, Sholler GF, Celermajer DS. Left atrial size increases with body mass index in children.
International journal of cardiology. 2010; 141:61–67. [PubMed: 19147240]
22. Yu JJ, Yeom HH, Chung S, Park Y, Lee DH. Left atrial diameters in overweight children with
normal blood pressure. J Pediatr. 2006; 148:321–325. [PubMed: 16615959]
Gidding et al. Page 8
Pediatr Cardiol. Author manuscript; available in PMC 2015 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
23. Daniels SR, Witt SA, Glascock B, Khoury PR, Kimball TR. Left atrial size in children with
hypertension: The influence of obesity, blood pressure, and left ventricular mass. J Pediatr. 2002;
141:186–190. [PubMed: 12183712]
24. Chinali M, de Simone G, Roman MJ, Best LG, Lee ET, Russell M, Howard BV, Devereux RB.
Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: The strong
heart study. J Am Coll Cardiol. 2008; 52:932–938. [PubMed: 18772065]
25. Toprak A, Wang H, Chen W, Paul T, Ruan L, Srinivasan S, Berenson G. Prehypertension and
black-white contrasts in cardiovascular risk in young adults: Bogalusa heart study. J Hypertens.
2009; 27:243–250. [PubMed: 19226697]
26. Hietalampi H, Pahkala K, Jokinen E, Ronnemaa T, Viikari JS, Niinikoski H, Heinonen OJ, Salo P,
Simell O, Raitakari OT. Left ventricular mass and geometry in adolescence: Early childhood
determinants. Hypertension. 2012; 60:1266–1272. [PubMed: 22987921]
27. Liao Y, Cooper RS, McGee DL, Mensah GA, Ghali JK. The relative effects of left ventricular
hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults.
JAMA. 1995; 273:1592–1597. [PubMed: 7745772]
28. Dhuper S, Abdullah RA, Weichbrod L, Mahdi E, Cohen HW. Association of obesity and
hypertension with left ventricular geometry and function in children and adolescents. Obesity
(Silver Spring). 2011; 19:128–133. [PubMed: 20559301]
29. Richey PA, Disessa TG, Somes GW, Alpert BS, Jones DP. Left ventricular geometry in children
and adolescents with primary hypertension. Am J Hypertens. 2010; 23:24–29. [PubMed:
19851297]
30. Daniels SR, Loggie JM, Khoury P, Kimball TR. Left ventricular geometry and severe left
ventricular hypertrophy in children and adolescents with essential hypertension. Circulation. 1998;
97:1907–1911. [PubMed: 9609083]
31. Di Bonito P, Moio N, Scilla C, Cavuto L, Sibilio G, Sanguigno E, Forziato C, Saitta F, Iardino
MR, Di Carluccio C, Capaldo B. Usefulness of the high triglyceride-to-hdl cholesterol ratio to
identify cardiometabolic risk factors and preclinical signs of organ damage in outpatient children.
Diabetes Care. 2012; 35:158–162. [PubMed: 22040842]
32. Gutin B, Treiber F, Owens S, Mensah GA. Relations of body composition to left ventricular
geometry and function in children. J Pediatr. 1998; 132:1023–1027. [PubMed: 9627597]
33. Border WL, Kimball TR, Witt SA, Glascock BJ, Khoury P, Daniels SR. Diastolic filling
abnormalities in children with essential hypertension. J Pediatr. 2007; 150:503–509. [PubMed:
17452225]
34. Van Putte-Katier N, Rooman RP, Haas L, Verhulst SL, Desager KN, Ramet J, Suys BE. Early
cardiac abnormalities in obese children: Importance of obesity per se versus associated
cardiovascular risk factors. Pediatr Res. 2008; 64:205–209. [PubMed: 18391840]
35. DeLoach SS, Daskalakis C, Gidding S, Falkner B. Central blood pressures are associated with left
ventricular mass index among african-american adolescents. Am J Hypertens. 2012; 25:41–45.
[PubMed: 21976275]
36. Dorresteijn JA, Visseren FL, Spiering W. Mechanisms linking obesity to hypertension. Obes Rev.
2012; 13:17–26. [PubMed: 21831233]
37. Dustan HP. Obesity and hypertension. Diabetes Care. 1991; 14:488–504. [PubMed: 1864221]
Gidding et al. Page 9
Pediatr Cardiol. Author manuscript; available in PMC 2015 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Gidding et al. Page 10
Table 1
Echocardiogram data summary by gender
Variable
Mean (SD) or Geometric Mean [Q1, Q3]
All Subjects
(N = 280)
Male
(N = 148)
Female
(N = 132)
Aortic Root (cm) 2.59 (0.31) 2.67 (0.31) 2.51 (0.30)
Left Atrium (cm) 3.34 (0.51) 3.36 (0.49) 3.33 (0.53)
Left Vent Dimension/Diastole (cm) 4.86 (0.49) 5.03 (0.42) 4.66 (0.49)
Left Vent Posterior Wall Thickness/Diastole (cm) 0.87 (0.16) 0.90 (0.15) 0.83 (0.16)
Intraventricular Septal Thickness/Diastole (cm) 0.83 (0.13) 0.88 (0.13) 0.78 (0.12)
Left Ventricular Shortening Fraction (%) 36.32 (5.28) 35.53 (5.41) 37.21 (4.99)
Left Ventricular Mass (gm) 143.07 (41.85) 160.60 (40.94) 123.40 (33.35)
MV E (m/sec) 0.97 (0.56) 0.99 (0.75) 0.94 (0.18)
E’ (m/sec) ‡ 0.18 [0.15, 0.20] 0.18 [0.15, 0.20] 0.17 [0.15, 0.20]
DTI Ratio 5.66 (1.48) 5.55 (1.41) 5.79 (1.55)
‡
Data natural log transformed: geometric means with [first quartile, third quartile] presented
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Table 2
Data summary by tertile-based categories (low, moderate, high) of left-atrial diameter
index (LADI)
Variable
Categorical Variables: Frequencies (Percents)
Continuous Variables: Mean (SD) or Geometric Mean [Q1,Q3]
Low
LADI ≤ 1.87
(N = 94)
Moderate
1.87 < LADI ≤ 2.12
(N = 93)
High
LADI > 2.12
(N = 93)
3-way
p-value†
Age (yrs) 16.18 (1.64) 16.14 (1.69) 16.30 (1.72) 0.82
Gender Female 39 (41.5%) 41 (44.1%) 52 (55.9%) 0.19
BP ≥120/80 26 (27.7%) 25 (26.9%) 29 (31.2%) 0.82
Heart Rate (bpm) ‡ 70.8 [64, 78] 69.7 [64, 76] 71.8 [64, 80] 0.02
Height (m) 1.71 (0.08) 1.68 (0.09) 1.67 (0.10) 0.01
BMI (kg/m2) ‡ 24.32 [20.44, 27.33] 28.04 [24.89, 32.39] 33.32 [28.58, 39.46] <.01
BMI z-score 0.78 (1.01) 1.45 (0.91) 1.94 (0.88) <.01
Waist Circumference (cm) ‡ 78.16 [70.00, 87.00] 85.71 [75.00, 97.40] 96.99 [85.00, 114.0] <.01
SBP (mmHg) ‡ 112.05 [104.3, 121.0] 112.56 [104.7, 120.0] 115.04 [108.7, 122.7] 0.19
SBP z-score −0.23 (0.96) −0.08 (0.97) 0.20 (0.92) 0.02
DBP (mmHg) ‡ 63.52 [59.00, 69.67] 61.50 [56.83, 67.00] 62.21 [57.67, 67.00] 0.25
DBP z-score −0.27 (0.60) −0.37 (0.70) −0.33 (0.66) 0.58
Heart rate (bpm) ‡ 70.82 [64.0, 78.0] 69.75 [64.0, 76.0] 71.85 [64.0, 80.0] 0.44
HOMA (mg/dl) ‡ 1.55 [0.98, 2.21] 1.79 [1.05, 3.38] 2.32 [1.33, 3.52] 0.02
Adiponectin (ug/ml) ‡ 6.24 [4.30, 9.30] 5.27 [3.90, 8.20] 5.15 [3.45, 8.65] 0.10
IL6 (pg/ml) ‡ 2.78 [1.90, 3.90] 3.06 [2.10, 4.20] 2.95 [2.10, 4.10] 0.61
PAI1 (ng/ml) 50.43 (24.87) 58.86 (27.55) 69.21 (25.63) <.01
TNF-α (pg/ml) ‡ 8.88 [7.30, 10.60] 8.01 [7.10, 8.90] 8.22 [6.75, 9.55] 0.25
TNF-αR (pg/ml) ‡ 0.88 [0.70, 1.10] 0.93 [0.80, 1.20] 0.96 [0.80, 1.20] 0.35
hsCRP (mg/dl) ‡ 0.51 [0.20, 1.10] 0.77 [0.30, 1.70] 1.13 [0.40, 3.50] <.01
LVMI (g/[height in m]^2.7) 30.59 (7.06) 34.95 (7.13) 38.27 (7.96) <.01
LV RWT (cm/m of height) ‡ 0.36 [0.32, 0.41] 0.35 [0.31, 0.41] 0.35 [0.30, 0.39] 0.43
DTI Ratio 5.39 (1.23) 5.71 (1.49) 5.89 (1.66) 0.10
†
Fishers exact test (categorical) or ANOVA F-test (continuous): any groups different (3-way comparison test)
‡
Data natural log transformed: geometric means with [first quartile, third quartile] presented
Pediatr Cardiol. Author manuscript; available in PMC 2015 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Gidding et al. Page 12
Table 3
Data Summary by LV Geometry and LV mass index groupings
Variable>
Categorical Variables: Frequencies (Percents)
Continuous Variables: Mean (SD) or Geometric Mean [Q1,Q3]
Normal
(N = 161)
Concentric
Remodeling
(N = 32)
Eccentric LVH
(N = 58)
Concentric LVH
(N = 29) p-value†
Age (yrs) 16.01 (1.69) 16.40 (1.79) 16.40 (1.70) 16.71 (1.34) 0.13
Gender Female 78 (48.4%) 18 (56.3%) 24 (41.4%) 12 (41.4%) 0.58
BP ≥120/80 31 (19.3%) 8 (25.0%) 26 (44.8%) 15 (51.7%) <.01
Heart rate 71.3 [64, 80] 73.3 [66, 78] 68.6 [62, 78] 69.0 [62, 72] 0.02
Height (m) 1.68 (0.09) 1.67 (0.09) 1.69 (0.09) 1.72 (0.10) 0.25
BMI (kg/m2) ‡ 26.49 [21.97,31.86]
25.99 [20.69, 32.01] 34.26 [28.26, 42.59] 30.71 [23.79, 37.51] <.01
BMI z-score 1.19 (1.03) 1.01 (1.16) 2.04 (0.77) 1.62 (0.94) <.01
Waist Circumference (cm)
‡
82.00 [71.00,
91.75]
82.77 [70.05, 95.24] 99.94
[84.50,118.10]
92.30 [75.50,110.50] <.01
SBP (mmHg) ‡ 110.98[105.0,118.00]
113.09
[104.0,120.44]
116.87
[108.3,126.00]
118.77
[109.7,127.33]
0.01
SBP z-score −0.22 (0.84) 0.02 (1.06) 0.26 (1.04) 0.32 (1.11) 0.01
DBP (mmHg) ‡ 61.78 [57.67,67.00]
62.86 [58.67, 67.00] 62.80 [57.67, 69.00] 64.71 [60.00, 69.67] 0.33
DBP z-score −0.35 (0.64) −0.27 (0.60) −0.33 (0.76) −0.21 (0.61) 0.71
Heart rate (bpm) ‡ 71.38 [64.0, 80.0] 73.31 [66.0, 78.0] 68.6 [62.0, 78.0] 69.0 [62.0, 72.0] 0.18
HOMA (mg/dl) ‡ 1.67 [0.99, 2.71] 1.97 [1.29, 3.40] 2.30 [1.38, 3.92] 2.11 [1.23, 3.26] 0.04
Adiponectin (ug/ml) ‡ 5.77 [4.00, 8.70] 5.87 [3.65, 9.69] 5.37 [3.80, 7.50] 4.37 [2.65, 7.50] 0.35
IL6 (pg/ml) ‡ 2.94 [2.00, 4.10] 2.54 [2.00, 3.40] 3.21 [2.20, 4.90] 2.79 [1.95, 3.90] 0.44
PAI1 (ng/ml) 56.60 (25.04) 53.19 (29.45) 69.81 (27.05) 62.13 (30.75) 0.03
TNF-α (pg/ml) ‡ 8.48 [7.00, 9.90] 8.28 [7.30, 10.10] 8.51 [6.85, 9.90] 7.57 [6.75, 8.90] 0.46
TNF-αR (pg/ml) ‡ 0.92 [0.70, 1.10] 0.91 [0.60, 1.10] 0.97 [0.80, 1.20] 0.86 [0.70, 1.05] 0.48
hsCRP (mg/dl) ‡ 0.66 [0.20, 1.70] 0.87 [0.30, 1.95] 1.18 [0.60, 3.15] 0.65 [0.24, 1.77] 0.04
LVMI (g/[height in m]^2.7) 30.24 (5.24) 31.04 (5.15) 43.10 (3.63) 45.61 (5.26)
LV RWT (cm/m of
height) ‡
0.32 [0.29, 0.36] 0.46 [0.42, 0.48] 0.34 [0.32, 0.38] 0.47 [0.42, 0.49]
DTI Ratio 5.38 (1.35) 6.39 (1.76) 5.69 (1.50) 6.43 (1.33) 0.01
LVMI: left ventricular mass index; LV RWT: left ventricular relative wall thickness.
High LVMI: ≥36.9 (females), 39.4 (males); High LVRWT: ≥ 0.41
†
Fishers exact test (categorical) or ANOVA F-test (continuous): any groups different (4-way comparison test)
‡
Data natural log transformed: geometric means with [first quartile, third quartile] presented
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